Director/PDMR Shareholding

August 01, 2018

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 27 July 2018, it purchased 525,000 ordinary shares and 118,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") at 3.49p and 3.5p respectively per Ordinary Share (the “Purchase”). Following the purchase, Vulpes has a total direct and indirect interest in 56,031,431 equivalent to 18.98% of Proteome Sciences' total issued share capital.

Back to News